Sort by
Keyphrases
Diabetic
74%
Randomized Double-blind Controlled Trial
57%
Serum Urate
57%
Urate-lowering Therapy
57%
STZ-induced
57%
PIM-1
57%
MicroRNA
57%
Pro-survival
57%
Cardiomyopathy
57%
Rapid Onset
57%
High-density Lipoprotein Cholesterol (HDL-C)
57%
Cardio
57%
Lipoprotein Levels
57%
Diagnostic Sensitivity
57%
Gout
57%
Diabetic Mice
57%
Girmit
57%
Boiled Rice
57%
Famine
57%
Feasting
57%
Migrant Health
57%
MicroRNA-1 (miR-1)
54%
Bone Erosion
28%
STZ-induced Diabetes
22%
Female Advantage
22%
Diabetic Heart
22%
Molecular Mechanism
22%
Health Impact
22%
Molecular Alterations
14%
Serum Urate Levels
14%
Allopurinol
14%
Blood Samples
14%
OMERACT
14%
Non-diabetic
14%
Reverse Transcription
14%
Between-group Difference
14%
Circulating microRNA
14%
Circulating miRs
14%
Core Outcome Domains
14%
Computed Tomography
14%
Potential Biomarkers
14%
Coronary Artery Bypass Graft Surgery
14%
Total RNA
14%
Peripheral Blood
14%
Ischemic Heart Disease
14%
Specific Primers
14%
Apoptotic Caspases
11%
Parameter Measurement
11%
Streptozotocin
11%
Diabetic Cardiomyopathy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
microRNA
63%
Urate
57%
Myocardial Disease
57%
Gout
57%
High Density Lipoprotein
57%
microRNA 1
49%
Bone Erosion
19%
Biological Marker
14%
Ischemic Heart Disease
14%
Circulating microRNA
14%
Streptozotocin-Induced Diabetes Mellitus
12%
Allopurinol
9%
Adverse Event
9%
CD-1 Mouse
6%
Heart Ventricle Remodeling
6%
Streptozotocin
6%
Diastolic Dysfunction
6%
Diabetic Cardiomyopathy
6%
Caspase 3
6%
Preclinical Study
6%
Congestive Heart Failure
6%
Medicine and Dentistry
Urate
57%
Gout
57%
Migrant Health
57%
Oral
57%
Pulse Rate
57%
Infancy
28%
Health Outcomes
28%
Ethnic Minority Group
28%
Health Inequity
28%
Health Disparity
28%
Nutritional Deficiency
28%
Bone Erosion
19%
Allopurinol
9%
Computer Assisted Tomography
9%
Rheumatology
9%
Adverse Event
9%
